Amicus Therapeutics (FOLD) Tops Q3 EPS by 3c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates
November 4, 2025 7:01 AM ESTQ3 2025 Total Revenue of $169M, up 17% at CER
Positive Q3 2025 GAAP Net Income of $17M
Cash Position of $264M, a $33M Increase in Q3 2025
Conference Call and Webcast Today at 8:30 a.m. ET
PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:... More
